# Lisa R. Sammaritano

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/lisa-r-sammaritano/

## Facts

| Field | Value |
| --- | --- |
| Citations | 12,996 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 51 |
| i10-index | 85 |
| Last Known Institution | Twitter (United States) |
| OpenAlex ID | https://openalex.org/A5068243428 |
| ORCID iD | 0000-0003-2387-5363 |
| Works | 163 |

## Researcher papers

- [Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus](https://scholariq.org/papers/prevalence-and-correlates-of-accelerated-atherosclerosis-in-systemic-lupus/)
- [Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus](https://scholariq.org/papers/combined-oral-contraceptives-in-women-with-systemic-lupus-erythematosus/)
- [2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases](https://scholariq.org/papers/2020-american-college-of-rheumatology-guideline-for-the-management-of/)
- [The Effect of Combined Estrogen and Progesterone Hormone Replacement Therapy on Disease Activity in Systemic Lupus Erythematosus: A Randomized Trial](https://scholariq.org/papers/the-effect-of-combined-estrogen-and-progesterone-hormone-replacement-therapy-on/)
- [Predictors of Pregnancy Outcomes in Patients With Lupus](https://scholariq.org/papers/predictors-of-pregnancy-outcomes-in-patients-with-lupus/)
- [Systemic Lupus Erythematosus](https://scholariq.org/papers/systemic-lupus-erythematosus-7/)
- [2023 ACR/EULAR antiphospholipid syndrome classification criteria](https://scholariq.org/papers/2023-acr-eular-antiphospholipid-syndrome-classification-criteria/)
- [Activation of cultured vascular endothelial cells by antiphospholipid antibodies.](https://scholariq.org/papers/activation-of-cultured-vascular-endothelial-cells-by-antiphospholipid-antibodies/)
- [Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: A randomized, double‐blind, placebo‐controlled trial in asymptomatic antiphospholipid antibody–positive individuals](https://scholariq.org/papers/aspirin-for-primary-thrombosis-prevention-in-the-antiphospholipid-syndrome-a/)
- [Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies](https://scholariq.org/papers/prediction-of-adverse-pregnancy-outcome-by-the-presence-of-lupus-anticoagulant/)
- [A Qualitative Analysis of Patient Perspectives and Preferences in Lupus Management to Guide Lupus Guidelines Development](https://scholariq.org/papers/a-qualitative-analysis-of-patient-perspectives-and-preferences-in-lupus/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Pregnancy and Medication Impact](https://scholariq.org/topics/pregnancy-and-medication-impact/)
- [Reproductive System and Pregnancy](https://scholariq.org/topics/reproductive-system-and-pregnancy/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)

## Researcher university

- [Twitter (United States)](https://scholariq.org/institutions/twitter-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.